InsiderTrades

Form 4 for INCY Incyte

Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-26 · accession 0001104659-25-019280 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-28 2025-02-26 INCY Denton Sheila A. EVP, GC M - OptEx $58.06 +9,574 39.9K +32% +$555.9K
DM 2025-02-28 2025-02-26 INCY Denton Sheila A. EVP, GC S - Sale+OE $74.07 -14.1K 25.8K -35% -$1.04M
D 2025-02-28 2025-02-26 INCY Denton Sheila A. EVP, GC M - OptEx $0.00 -9,574 19.2K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-26 M A 9,574 $58.06 39,917 D — —
2 Common Common Stock 2025-02-26 S D 9,574 $74.07 30,343 D — —
3 Common Common Stock 2025-02-26 S D 4,495 $74.08 25,848 D — — (F1) This includes an aggregate of 25,848 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not vested.
4 Derivative Employee Stock Option (right to buy) 2025-02-26 M D 9,574 $0.00 19,151 D $58.06 · — to 2033-10-02 9,574 Common Stock (F2) Beginning October 2, 2023, options become exercisable in 37 installments, with the first 25% vesting on October 2, 2024 and the remainder vesting monthly over three years.